Tourmaline Bio, Inc.

Tourmaline Bio, Inc.verified

TRML

Price:

$47.98

Market Cap:

$1.23B

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.

Industry

Biotechnology

IPO Date

2021-05-07

Stock Exchange

NASDAQ

Ticker

TRML

The Enterprise Value as of November 2025 (TTM) for Tourmaline Bio, Inc. (TRML) is 1.20B

According to Tourmaline Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.20B. This represents a change of 158.80% compared to the average of 464.20M of the last 4 quarters.

Tourmaline Bio, Inc. (TRML) Historical Enterprise Value (quarterly & annually)

How has TRML Enterprise Value performed in the past?

The mean historical Enterprise Value of Tourmaline Bio, Inc. over the last ten years is 505.95M. The current 1.20B Enterprise Value has changed 23.64% with respect to the historical average. Over the past ten years (40 quarters), TRML's Enterprise Value was at its highest in in the March 2022 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

505.95M

Median

341.74M

Minimum

-16034540.00

Maximum

1.64B

Tourmaline Bio, Inc. (TRML) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tourmaline Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.71%

Maximum Annual Enterprise Value = 1.64B

Minimum Annual Increase = -3117.21%

Minimum Annual Enterprise Value = -16034540.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024483.80M-3117.21%
2023-16034540.00-108.03%
2022199.68M-87.86%
20211.64B1.71%
202091.04M-85.61%

Tourmaline Bio, Inc. (TRML) Average Enterprise Value

How has TRML Enterprise Value performed in the past?

The current Enterprise Value of Tourmaline Bio, Inc. (TRML) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

222.48M

5-year avg

480.56M

10-year avg

505.95M

Tourmaline Bio, Inc. (TRML) Enterprise Value vs. Peers

How is TRML’s Enterprise Value compared to its peers?

Tourmaline Bio, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (2.30B), less than Precigen, Inc. (1.22B), greater than Immatics N.V. (919.37M), greater than ORIC Pharmaceuticals, Inc. (1.06B), greater than Enliven Therapeutics, Inc. (1.15B), greater than Amylyx Pharmaceuticals, Inc. (985.24M), less than Relay Therapeutics, Inc. (1.33B), less than Dianthus Therapeutics, Inc. (1.56B), greater than Wave Life Sciences Ltd. (1.07B), less than Syndax Pharmaceuticals, Inc. (1.94B),

Build a custom stock screener for Tourmaline Bio, Inc. (TRML) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tourmaline Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tourmaline Bio, Inc. (TRML) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tourmaline Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tourmaline Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Tourmaline Bio, Inc. (TRML)?

What is the 3-year average Enterprise Value for Tourmaline Bio, Inc. (TRML)?

What is the 5-year average Enterprise Value for Tourmaline Bio, Inc. (TRML)?

How does the current Enterprise Value for Tourmaline Bio, Inc. (TRML) compare to its historical average?